NeuroOne Medical (NMTC) Technologies appointed Parag Patil, M.D., Ph.D., as Chief Medical Advisor, after serving on the company’s Scientific Advisory Board since 2018. Parag Patil is a neurosurgeon-engineer with 20 years’ experience serving patients and advancing innovative therapies to alleviate neurological disorders. After joining the faculty at the University of Michigan in 2005, he has served as an Associate Professor of Neurosurgery, Neurology, Anesthesiology, and Biomedical Engineering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NMTC:
- NeuroOne Faces Nasdaq Non-Compliance Notice
- NeuroOne Medical initiated with a Buy at Ladenburg
- NeuroOne Medical completes FDA submission for OneRF Ablation System RF
- NeuroOne Medical confirms ‘no material impact’ from global tariffs
- NeuroOne Medical sees FY25 product revenue $8M-$10M vs. $3.5M last year